As an example if you are diagnosed with a type
of deadly brain cancer, perhaps you can receive part of your payout early to help in fighting the cancer with an experimental treatment.
Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often
deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.
In a significant breakthrough, the Translational Genomics Research Institute (TGen) has identified a drug, propentofylline or PPF, that could help treat patients
with deadly brain cancer.
Gliomas are
deadly brain cancers whose progression is strongly associated with overexpression of the RNA - binding regulatory protein HuR.
La Jolla, CA — Researchers at the Salk Institute for Biological Studies have developed a versatile mouse model of glioblastoma — the most common and
deadly brain cancer in humans — that closely resembles the development and progression of human brain tumors that arise naturally.
«Cancer genes turned off in
deadly brain cancer.»
«Researchers identify immune genes tied to common,
deadly brain cancer.»
Researchers are now testing CAR - T therapies against other cancers, including pancreatic and
the deadly brain cancer glioblastoma.
A new population - based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of
the deadly brain cancer.
But a study targeting one
deadly brain cancer, medulloblastoma, ended in disappointment as the patient's once - tamed tumor quickly developed resistance to the drug and killed him.
La Jolla, CA — Researchers at the Salk Institute for Biological Studies have developed a versatile mouse model of glioblastoma — the most common and
deadly brain cancer in humans — that closely resembles...
Genome Atlas Group Reports on Brain Cancer Genes Johns Hopkins Kimmel Cancer Center investigators were part of The Cancer Genome Atlas (TCGA) which reported results from its first comprehensive study focused on
the deadly brain cancer glioblastoma.